Health-related quality of life in a racially diverse population screened for hemochromatosis: Results from the Hemochromatosis and Iron Overload Screening (HEIRS) study

Genetics in Medicine

Volumn 9, Issue 10, 2007, Pages 705-712

  Wenzel, Lari B ^a   Anderson, Roger ^b   Tucker, Diane C ^c   Palla, Shana ^b   Thomson, Elizabeth ^d   Speechley, Mark ^e   Harrison, Helen ^f   Lewis Jack, Ometha ^g   Fadojutimi Akinsiku, Margaret ^g   Eckfeldt, John H ^h   Reiss, Jacob A ⁱ   Rivers, Charles A ^c   Bookman, Ebony ^j   Snively, Beverly M ^b   McLaren, Christine E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF WESTERN ONTARIO   (Canada)

^f LONDON HEALTH SCIENCES CENTRE   (Canada)

^g HOWARD UNIVERSITY   (United States)

^h UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

ⁱ KAISER PERMANENTE   (United States)

^j NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

more..

Author keywords

Hemochromatosis; Iron overload; Multi ethnic population; Quality of life; Screening

Indexed keywords

FERRITIN; TRANSFERRIN;

ADULT; ANALYTIC METHOD; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; GENE; GENE MUTATION; GENETIC RISK; GENOTYPE; HEMOCHROMATOSIS; HEMOCHROMATOSIS GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIMARY MEDICAL CARE; QUALITY OF LIFE; RACE DIFFERENCE; SCREENING; STATISTICAL SIGNIFICANCE; TRANSFERRIN BLOOD LEVEL; WELLBEING;

ADULT; CONTINENTAL POPULATION GROUPS; FEMALE; GENOTYPE; HEMOCHROMATOSIS; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; QUALITY OF LIFE;

EID: 37349116983     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e3181571f31     Document Type: Article

References (19)

1. Powell LW, Bassett ML. Haemochromatosis: diagnosis and management after the cloning of the HFE gene. Aust N Z J Med 1998;28:159-163.
2. Harrison H, Adams PC. Hemochromatosis. Common genes, uncommon illness? Can Fam Physician 2002;48:1326-1333.
3. Njajou OT, Alizadeh BZ, van Duijn CM. Is genetic screening for hemochromatosis worthwhile? Eur J Epidemiol 2004;19:101-108.
4. Byrnes V, Ryan E, Barrett S, Kenny P, et al. Genetic hemochromatosis, a Celtic disease: is it now time for population screening? Genet Test 2001;5:127-130.
5. Anderson RT, Press N, Tucker DC, Snively BM, et al. Patient acceptability of genotypic testing for hemochromatosis in primary care. Genet Med 2005;7:557-563.
6. Hicken BL, Calhoun DC, Tucker DC. Genetic testing for hemochromatosis: attitudes and acceptability among young and older adults. Genet Test 2003;7:235-239.
7. Hicken BL, Calhoun DA, Barton JC, Tucker DC. Attitudes about and psychosocial outcomes of HFE genotyping for hemochromatosis. Genet Test 2004;8:90-97.
8. Power TE, Adams PC. Psychosocial impact of C282Y mutation testing for hemochromatosis. Genet Test 2001;5:107-110.
9. Shaheen NJ, Lawrence LB, Bacon BR, Barton JC, et al. Insurance, employment, and psychosocial consequences of a diagnosis of hereditary hemochromatosis in subjects without end organ damage. Am J Gastroenterol 2003;98:1175-1180.
10. Delatycki MB, Allen KJ, Nisselle AE, Collins V, et al. Use of community genetic screening to prevent HFE-associated hereditary haemochromatosis. Lancet 2005;366:314-316.
11. McLaren C, Barton J, Adams P, Harris E, et al. Hemochromatosis and iron overload screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults. Am J Med Sci 2003;325:53-62.
12. Adams PC, Reboussin DM, Barton JC, McLaren CE, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005;352:1769-1778.
13. Ware J, Kosinski M, Gandek B. SF-36 health survey: manual and interpretation guide. Lincoln, RI: QualityMetric, 2002:14.
14. Bowen DJ, Patenaude AF, Vernon SW. Psychosocial issues in cancer genetics: from the laboratory to the public. Cancer Epidemiol Biomarkers Prev 1999;8:326-328.
15. Anderson R, Wenzel L, Walker A, Ruggiero A, et al. Impact of hemochromatosis screening in patients with indeterminate results: The hemochromatosis and iron overload screening study. Genet Med 2006;8:681-687.
16. Sloan J, Cella D, Hays R. Clinical significance of patient-reported questionnaire data: another step twoard consensus. J Clin Epidemiol 2005;58:1217-1219.
17. Cella D, Hughes C, Peterman A, Chang CH, et al. A brief assessment of concerns associated with genetic testing for cancer: the multidimensional impact of cancer risk assessment (MICRA) questionnaire. Health Psychol 2002;21:564-572.
18. Coyne J, Benazon N, Gaba C, Calzone K, et al. Distress and psychiatric morbidity among women from high-risk breast and ovarian cancer families. J Consult Clin Psychol 2000;68:864-874.
19. Gonzalez Burchard E, Ziv E, Coyle N, Gomez S, et al. The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med 2003;348:1170-1175.